Britannia Life Sciences Inc. (CSE:BLAB)
Canada
· Delayed Price · Currency is CAD 0.100
-0.010 (-9.09%)
Mar 9, 2026, 11:17 AM EST
Britannia Life Sciences Revenue
Britannia Life Sciences had revenue of 377.01K CAD in the quarter ending December 31, 2025, a decrease of -78.31%. This brings the company's revenue in the last twelve months to -1.00M, down -68.65% year-over-year. In the fiscal year ending March 31, 2025, Britannia Life Sciences had annual revenue of 369.28K, down -28.55%.
Revenue (ttm)
-1.00M
Revenue Growth
-68.65%
P/S Ratio
113.19
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.85M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rapid Dose Therapeutics | 2.78M |
| Innovotech | 4.46M |
| Pharmala Biotech Holdings | 754.64K |
| Telescope Innovations | 6.28M |
| Microbix Biosystems | 16.76M |
| Devonian Health Group | 18.52M |